APS Healthcare, Inc (APS) offers healthcare purchasers a solution to the challenge of providing mental health and substance abuse benefits without skyrocketing costs. They work with some of the nation's largest health plans and corporate employers, serving over three million members through networks in 20 states and the District of Columbia. Big enough to deliver yet small enough to care, APS offers a refreshing, personal alternative to the choices available in today's market.

Cambridge Heart, Inc. (Nasdaq: CAMH) manufactures the CH 2000, the first non-invasive medical device to diagnose patients at risk for ventricular arrhythmia and sudden cardiac death. Sudden cardiac death results from electrical instabilities in the heart and causes approximately 50% of all heart attacks. Cambridge Heart executed a successful $22.5 million initial public offering in August 1996.

ONE-Inc develops and manages surgery centers of two kinds for high-volume anterior segment ophthalmic surgeons whose most important surgical procedures include cataract surgery and laser vision correction surgery (also called refractive surgery or LASIK). Cataract surgery is performed in outpatient ambulatory surgery centers and refractive surgery is performed in specialized refractive surgery centers under the brand name LaserOne.

Gynétics, Inc. is a women's healthcare company founded to develop, market and distribute pharmaceutical products and medical devices designed to advance the healthcare of women. The Company's current product focus is on the $1.6 billion contraception market as well as on the reproductive medicine market.

KBL Healthcare Acquisition Corporation was organized by the principals of KBL as a publicly-traded, $17.25 million pool of capital with the objective of acquiring an operating business in the healthcare industry within 18 months. In the summer of 1994, KBLHAC management arranged a merger with Concord Health Group, Inc. Concord Health Group was a profitable, well-managed and rapidly-growing regional developer, owner and operator of assisted living and long-term care facilities. In February 1996, Concord Health Group was sold to The Multicare Companies, a leading publicly-traded nursing home company.

Neuromedical Systems, Inc. (Nasdaq: NSIX). NSI's objective is to become the premier supplier of cytology screening and anatomic pathology diagnostic equipment and services to laboratories. NSI's first product, the PapNet Testing System, helps the laboratory increase the accuracy of cervical screening by displaying potentially abnormal cells for review and analysis by a cytology professional. Neuromedical Systems executed a successful $90 million initial public offering in December 1995.

iPhysician Net, based in Scottsdale, Arizona, provides applications and services that improve communications between the physician community, the pharmaceutical industry, and other key healthcare constituencies. They provide the physician with a direct and instant portal to multiple sources of healthcare information which can be accessed in a convenient and timely manner. They provide the pharmaceutical industry with enhanced opportunities for improved quality and frequency of communications with physicians, as well as a means of delivering informational and educational services within the pharmaceutical company's own organization.